Computational Drug Repurposing
Computational Drug Repurposing is a systematic academic approach within drug discovery that leverages computational methods to identify novel therapeutic applications for existing drugs by analyzing molecular, biological, and clinical data.
1K
Publications
65.8K
Citations
5.3K
Authors
1.8K
Institutions
Publications per year
2017–2026
866
Variants
Computational Drug RepositioningIn Silico Drug Repurposing
Parents
1K
Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2
Yadi Zhou, Yuan Hou, Jiayu Shen et al. · Cell Discovery · 2020 · 1.7K citations · Full text
1–5 of 1K
5.3K
Cleveland Clinic Lerner College of Medicine, United States
12 publications · 3.5K citations
11
h-index
11
h-index
9
h-index
8
h-index
Collaborations Pharmaceuticals (United States), United States
7 publications · 1K citations
7
h-index
1–5 of 5.3K
1.8K
Case Western Reserve University
Cleveland, United States
19 h-index
35 publications
5.7K citations
Harvard University
Cambridge, United States
18 h-index
88 publications
10.2K citations

Chinese Academy of Sciences
Beijing, China
17 h-index
99 publications
5.6K citations

Icahn School of Medicine at Mount Sinai
New York, United States
16 h-index
124 publications
15.5K citations
Stanford University
Stanford, United States
16 h-index
46 publications
9.1K citations

Cornell University
Ithaca, United States
15 h-index
58 publications
2.7K citations
City University of New York
New York, United States
14 h-index
34 publications
2.2K citations
University of Chinese Academy of Sciences
Beijing, China
13 h-index
47 publications
2.5K citations
1–8 of 1.8K
51 publications · 2.6K citations
28
h-index
38 publications · 1.9K citations
26
h-index
29 publications · 4.4K citations
23
h-index
22 publications · 1.3K citations
19
h-index
Repository · 30 publications · 1.2K citations
18
h-index
1–5